Tribenzor is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Cosette Pharmaceuticals, Inc.. The primary component is Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil.
| Product ID | 0713-0875_e1ab644d-b624-3cf3-e053-2995a90addb0 | 
| NDC | 0713-0875 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Tribenzor | 
| Generic Name | Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2022-06-15 | 
| Marketing Category | NDA / | 
| Application Number | NDA200175 | 
| Labeler Name | Cosette Pharmaceuticals, Inc. | 
| Substance Name | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL | 
| Active Ingredient Strength | 5 mg/1; mg/1; mg/1 | 
| Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2022-06-15 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0713-0874 | Tribenzor | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| 0713-0875 | Tribenzor | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| 0713-0876 | Tribenzor | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| 0713-0877 | Tribenzor | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| 0713-0878 | Tribenzor | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| 65597-114 | Tribenzor | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| 65597-115 | Tribenzor | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| 65597-117 | Tribenzor | Tribenzor | 
| 65597-116 | Tribenzor | Tribenzor | 
| 65597-118 | Tribenzor | Tribenzor | 
| 49884-786 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| 49884-787 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| 49884-788 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| 49884-789 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| 49884-790 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| 63629-2238 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| 63629-2239 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| 63629-2240 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| 63629-2241 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  TRIBENZOR  85416907  4142005 Live/Registered | DAIICHI SANKYO COMPANY, LIMITED 2011-09-07 | 
|  TRIBENZOR  77744208  3982012 Live/Registered | DAIICHI SANKYO COMPANY, LIMITED 2009-05-26 |